Metabolic profiling of major vitamin D metabolites using Diels–Alder derivatization and ultra-performance liquid chromatography–tandem mass spectrometry

[1]  J. Adams,et al.  Transpleural gradient of 1,25-dihydroxyvitamin D in tuberculous pleuritis. , 1989, The Journal of clinical investigation.

[2]  G. Aldrovandi,et al.  Vitamins D Status in adolescents and young adults with HIV infection , 2006, American Journal of Clinical Nutrition.

[3]  J. Zerwekh.  The measurement of vitamin D: analytical aspects , 2004, Annals of clinical biochemistry.

[4]  S. Vermund,et al.  The REACH Project of the Adolescent Medicine HIV/AIDS Research Network: design, methods, and selected characteristics of participants. , 1998, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[5]  B. Hammock,et al.  Mass spectrometry-based metabolomics. , 2007, Mass spectrometry reviews.

[6]  Ravinder J. Singh,et al.  C-3 Epimers Can Account for a Significant Proportion of Total Circulating 25-hydroxyvitamin D in Infants, Complicating Accurate Measurement and Interpretation of Vitamin D Status , 2022 .

[7]  T. Higashi,et al.  Determination of 24,25-dihydroxyvitamin D(3) in human plasma using liquid chromatography-mass spectrometry after derivatization with a Cookson-type reagent. , 2001, Biomedical chromatography : BMC.

[8]  B. Boyan,et al.  Differential regulation of growth plate chondrocytes by 1alpha,25-(OH)2D3 and 24R,25-(OH)2D3 involves cell-maturation-specific membrane-receptor-activated phospholipid metabolism. , 2002, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[9]  A. Norman,et al.  Minireview: vitamin D receptor: new assignments for an already busy receptor. , 2006, Endocrinology.

[10]  B. Hollis,et al.  Vitamin D2 is much less effective than vitamin D3 in humans. , 2004, The Journal of clinical endocrinology and metabolism.

[11]  A. Kissmeyer,et al.  Sensitive analysis of 1α,25-dihydroxyvitamin D3 in biological fluids by liquid chromatography–tandem mass spectrometry , 2001 .

[12]  M. Holick.  Vitamin D: A millenium perspective , 2003, Journal of cellular biochemistry.

[13]  R. Bouillon,et al.  Structure-function relationships in the vitamin D endocrine system. , 1995, Endocrine reviews.

[14]  R. Vieth,et al.  The case against ergocalciferol (vitamin D2) as a vitamin supplement. , 2006, The American journal of clinical nutrition.

[15]  B. Boyan,et al.  24,25-(OH)2D3 regulates cartilage and bone via autocrine and endocrine mechanisms , 2001, Steroids.

[16]  B. Boyan,et al.  1α,25-Dihydroxyvitamin D3 and 24R,25-Dihydroxyvitamin D3 Modulate Growth Plate Chondrocyte Physiology via Protein Kinase C-Dependent Phosphorylation of Extracellular Signal-Regulated Kinase 1/2 Mitogen-Activated Protein Kinase. , 2002, Endocrinology.

[17]  T. Higashi,et al.  Application of 4-(4-Nitrophenyl)-1,2,4-triazoline-3,5-dione to Analysis of 25- Hydroxyvitamin D3 in Human Plasma by Liquid Chromatography/Electron Capture Atmospheric Pressure Chemical Ionization-Mass Spectrometry , 2003, Analytical sciences : the international journal of the Japan Society for Analytical Chemistry.

[18]  T. Higashi,et al.  Characterization of urinary metabolites of vitamin D(3) in man under physiological conditions using liquid chromatography-tandem mass spectrometry. , 2002, Journal of pharmaceutical and biomedical analysis.

[19]  H. DeLuca,et al.  Metabolism of vitamin D3-3H in human subjects: distribution in blood, bile, feces, and urine. , 1967, The Journal of clinical investigation.

[20]  M. Vogeser,et al.  Candidate reference method for the quantification of circulating 25-hydroxyvitamin D3 by liquid chromatography-tandem mass spectrometry. , 2004, Clinical chemistry.

[21]  B. Hammock,et al.  Development of a HPLC/tandem-MS method for the analysis of the larvicides methoprene, hydroprene, and kinoprene at trace levels using Diels-Alder derivatization. , 2005, Journal of agricultural and food chemistry.

[22]  E. Gunter,et al.  Measurement of Vitamin D metabolites: an international perspective on methodology and clinical interpretation , 2004, The Journal of Steroid Biochemistry and Molecular Biology.

[23]  Stephen R. Wilson,et al.  Electrospray ionization mass spectrometry of vitamin D derivatives , 1993 .

[24]  N. J. Freeman,et al.  Uncommon syndromes and treatment manifestations of malignancy: Case 3. Richter's syndrome heralded by refractory hypercalcemia. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  Glenville Jones,et al.  Enzymes involved in the activation and inactivation of vitamin D. , 2004, Trends in biochemical sciences.

[26]  J. Jaspan,et al.  Hypercalcemia in a Patient With AIDS and Pneumocystis Carinii Pneumonia , 1993 .

[27]  S. Rainbow,et al.  Routine isotope-dilution liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of the 25-hydroxy metabolites of vitamins D2 and D3. , 2005, Clinical chemistry.

[28]  O. Fiehn.  Metabolomics – the link between genotypes and phenotypes , 2004, Plant Molecular Biology.

[29]  D. Khanna,et al.  Hypercalcaemia: a clue to Mycobacterium avium intracellulare infection in a patient with AIDS. , 1999, International journal of clinical practice.

[30]  T. Higashi,et al.  Simultaneous determination of 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 in human plasma by liquid chromatography-tandem mass spectrometry employing derivatization with a Cookson-type reagent. , 2001, Biological & pharmaceutical bulletin.

[31]  Y. Aso,et al.  Ferrocene-based Diels-Alder derivatization for the determination of 1alpha-hydroxyvitamin D3 in rat plasma by high-performance liquid chromatography-electrospray tandem mass spectrometry. , 2005, Analytical biochemistry.

[32]  F. Chessa,et al.  Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy. , 2004, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[33]  J. Adams,et al.  Vitamin D metabolite-mediated hypercalcemia and hypercalciuria patients with AIDS- and non-AIDS-associated lymphoma. , 1989, Blood.

[34]  A. Norman,et al.  Hypercalcemia in an anephric patient with sarcoidosis: evidence for extrarenal generation of 1,25-dihydroxyvitamin D. , 1981, The New England journal of medicine.

[35]  K. Yarasheski,et al.  HIV-protease inhibitors impair vitamin D bioactivation to 1,25-dihydroxyvitamin D , 2003, AIDS.

[36]  D. Jw,et al.  Hypercalcemia in a patient with the acquired immunodeficiency syndrome and Mycobacterium avium intracellulare infection. , 1994 .

[37]  D. Desiderio,et al.  LC-MS/MS analysis of peptides with methanol as organic modifier: improved limits of detection. , 2004, Analytical chemistry.

[38]  N. Horiuchi,et al.  Mouse Vitamin D-24-Hydroxylase: Molecular Cloning, Tissue Distribution, and Transcriptional Regulation by 1α,25-Dihydroxyvitamin D3. , 1997, Endocrinology.

[39]  I. Schuster,et al.  1α,25-Dihydroxy-3-epi-vitamin D3 a physiological metabolite of 1α,25-dihydroxyvitamin D3: Its production and metabolism in primary human keratinocytes , 2000, Molecular and Cellular Endocrinology.